4//SEC Filing
Krieger Nancy 4
Accession 0000899243-22-030932
CIK 0001827506other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:30 PM ET
Size
5.1 KB
Accession
0000899243-22-030932
Insider Transaction Report
Form 4
Krieger Nancy
Chief Medical Officer
Transactions
- Award
Common Stock
2022-09-10+80,000→ 330,233 total
Footnotes (1)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest as to 50% of the underlying shares on July 1, 2023 and the remaining 50% on July 1, 2024, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Talaris Therapeutics, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001845672
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:30 PM ET
- Size
- 5.1 KB